Plasmacytoid urothelial carcinoma of the urinary bladder: Clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis of a case series

Human Pathology

Volumn 42, Issue 8, 2011, Pages 1149-1158

  Raspollini, Maria Rosaria ^a   Sardi, Iacopo ^a   Giunti, Laura ^a   Di Lollo, Simonetta ^b   Baroni, Gianna ^b   Stomaci, Niceta ^c   Menghetti, Iacopo ^a   Franchi, Alessandro ^b  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c Institute of General Pathology   (Italy)

Author keywords

Chemotherapy; GATA 3; ISH analysis; p53 mutation; Plasmacytoid bladder carcinoma; Ultrastructural analysis

Indexed keywords

CARBOPLATIN; CD15 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CHROMOGRANIN; CYTOKERATIN 20; CYTOKERATIN 7; CYTOKERATIN 8; CYTOKERATIN AE1; CYTOKERATIN AE3; EPITHELIAL MEMBRANE ANTIGEN; HERMES ANTIGEN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; INTERFERON REGULATORY FACTOR 4; KI 67 ANTIGEN; PODOPLANIN; PROTEIN P16; PROTEIN P53; PROTEIN S 100; SYNAPTOPHYSIN; SYNDECAN 1; TRANSCRIPTION FACTOR GATA 3; UVOMORULIN;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; BLADDER EPITHELIUM; BREAST CARCINOMA; CANCER CELL; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CASE STUDY; CELL DIFFERENTIATION; CELL STRUCTURE; CYSTECTOMY; CYSTOSCOPY; ELECTRON MICROSCOPY; EPITHELIUM CELL; EXON; FEMALE; GENE SEQUENCE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; MOLECULAR GENETICS; MOLECULAR PATHOLOGY; MULTIMODALITY CANCER THERAPY; PHENOTYPE; PLASMA CELL; PLASMACYTOID UROTHELIAL CARCINOMA; RECTUM RESECTION; SQUAMOUS CELL; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; ULTRASTRUCTURE;

AGED; CARCINOMA, TRANSITIONAL CELL; DNA, NEOPLASM; FEMALE; GATA3 TRANSCRIPTION FACTOR; HUMANS; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; MUTATION; PLASMA CELLS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS;

EID: 79960397927     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2010.11.011     Document Type: Article

References (32)

1. Eble J.N., Sauter G., and Epstein J.I. Pathology and genetics: tumours of the urinary system and male genital organs. WHO Classification of Tumours 2004 IARC press Lyon
2. Ro J.Y., Shen S.S., and Lee H.I. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathological study of 9 cases Am J Surg Pathol 32 2008 752 757 (Pubitemid 351600823)
3. Mai K.T., Park P.C., and Yazdi H.M. Plasmacytoid urothelial carcinoma of the urinary bladder. Report of seven new cases Eur Urol 66 2006 1111 1114 (Pubitemid 44508780)
4. American Joint Committee on Cancer Cancer staging manual 7th ed 2009 Springer New York, NY
5. Higgins J.P.T., Kaygusuz G., and Wang L. Placental S-100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray Am J Surg Pathol 31 2007 673 680 (Pubitemid 46684205)
6. Alroy J., Pauli B.U., Hayden J.E., and Gould V.E. Intracytoplasmic lumina in bladder carcinomas Hum Pathol 10 1979 549 555 (Pubitemid 10241340)
7. Alroy J., Pauli B.U., and Weinstein R.S. Correlation between numbers of desmosomes and the aggressiveness of transitional cell carcinoma in human urinary bladder Cancer 47 1981 104 112 (Pubitemid 11167367)
8. Kumar Sm Kumar D., and Cowan D.F. Transitional cell carcinoma with rhabdoid features Am J Surg Pathol 16 1992 515 521
9. Russell P.J., Jelbart M., and Wills E. Establishment and characterization of a new human bladder cancer cell line showing features of squamous and glandular differentiation Int J Cancer 41 1988 74 82 (Pubitemid 18049353)
10. Offner F.A., Ott G., and Povey S. Characterization of the new bladder cancer cell line HOK-1: expression of transitional, squamous and glandular differentiation patterns Int J Cancer 49 1991 122 128
11. Raghavan D., Russell P.J., and Brown J.L. Experimental models of histogenesis and tumor cell heterogeneity in bladder cancer Semin Surg Oncol 8 1992 279 284
12. Tiguert R., Bianco F.J. Jr, and Oskanian P. Structural alteration of p53 protein in patients with muscle invasive bladder transitional cell carcinoma J Urol 166 2001 2155 2160 (Pubitemid 33065244)
13. Lu M.L., Wikman F., and Orntoft T.F. Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods Clin Cancer Res 8 2002 171 179 (Pubitemid 34101474)
14. Lowe S.W., Bodis S., and McClatchey A. p53 status and the efficacy of cancer therapy in vivo Science 4 1994 807 810 (Pubitemid 24359290)
15. Wattel E., Preudhomme C., and Hecquet B. p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies Blood 84 1994 3148 3157
16. Jansson T., Inganäs M., and Sjögren S. p53 status predicts survival in breast cancer patients treated with or without postoperative radiotherapy: a novel hypothesis based on clinical findings J Clin Oncol 13 1995 2745 2751
17. Righetti S.C., Della Torre G., and Pilotti S. A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma Cancer Res 56 1996 689 693 (Pubitemid 26055453)
18. Malats N., Bustos A., and Nascimento C.M. P53 as a prognostic marker for bladder cancer: a meta-analysis and review Lancet Oncol 6 2005 678 686 (Pubitemid 41222758)
19. Perrone F., Bossi P., and Cortelazzi B. TP53 mutations and pathologic complete response to neoadjuvant cisplatin and fluorouracil chemotherapy in resected oral cavity squamous cell carcinoma J Clin Oncol 28 2010 761 766
20. Erdemir F., Ozcan F., and Kilicaslan I. The relationship between the expression of E-cadherin and tumor recurrence and progression in high-grade stage T1 bladder urothelial carcinoma Int Urol Nephrol 39 2007 1031 1037 (Pubitemid 350193590)
21. Fritsche H.M., Burger M., and Denzinger S. Plasmacytoid urothelial carcinoma of the bladder: histological and clinical features of 5 cases J Urol 180 2008 1923 1927
22. Mastracci T.L., Tjan S., Bane A.L., O'Malley F.P., and Andrulis I.L. E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast Mod Pathol 18 2005 741 751 (Pubitemid 40780507)
23. Geramizadeh B., Adeli O.A., Rahsaz M., Mokhtari M., and Sefidbakht S. Comparison of the expression of cell adhesion molecule markers (E-cadherin and syndecan-1) between young and older age patients with gastric carcinoma J Gastrointest Cancer 2010 [Epub ahead of print]
24. Ross J.S., del Rosario A.D., Bui H.X., Kallakury B.V., Okby N.T., and Figge J. Expression of the CD44 cell adhesion molecule in urinary bladder transitional cell carcinoma Mod Pathol 9 1996 854 860 (Pubitemid 26279277)
25. Kalof A.N., Evans M.F., Simmons-Arnold L., Beatty B.G., and Kooper K. p16INK4a immunoexpression and HPV in situ hybridation signal patterns: potential markers of high-grade cervical intraepithelial neoplasia Am J Surg Pathol 29 2005 674 679 (Pubitemid 40577879)
26. Raspollini M.R., Nesi G., Baroni G., Girardi L.R., and Taddei G.L. p16(INK4a) expression in urinary bladder carcinoma Arch Ital Urol Androl 78 2006 97 100 (Pubitemid 44720497)
27. Yin M., Bastacky S., Parwani A.V., McHale T., and Dhir R. p16ink4 immunoreactivity is a realiable marker for urothelial carcinoma in situ Hum Pathol 39 2007 527 535
28. Nakazava K., Murata S., and Yuminamochi T. P16 expression analysis as an ancillar tool for cytologic diagnosis of urothelial carcinoma Am J Clin Pathol 132 2009 776 784
29. Buza N., Cohen P.J., Hui P., and Parkash V. Inverse p16 and p63 expression in small cell carcinoma and high-grade urothelial cell carcinoma of the urinary bladder Int J Surg Pathol 2010 [Epub ahead of print]
30. Lopez Beltran A., Requena M.J., Montironi R., Blanca A., and Cheng L. Plasmacytoid urothelial carcinoma of the bladder Hum Pathol 40 2009 1023 1028
31. Nigwekar P., Tamboli P., Amin M., Osunkoya A.O., Ben-Dor D., and Amin M.B. Plasmacytoid urothelial carcinoma: detailed analysis of morphology with clinicopathologic correlation in 17 cases Am J Surg Pathol 33 2009 417 424
32. Kohno T., Kitamura M., Akai H., Takaha M., Kawahara K., and Oka T. Plasmacytoid urothelial carcinoma of the bladder Int J Urol 13 2006 458 486